X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ALEMBIC PHARMA with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
TEVA PHARMA
Dec-13
ALEMBIC PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs7922,856-   
Low Rs4432,481-   
Sales per share (Unadj.) Rs167.01,639.0-  
Earnings per share (Unadj.) Rs38.2102.4-  
Cash flow per share (Unadj.) Rs42.0234.9-  
Dividends per share (Unadj.) Rs4.0089.63-  
Dividend yield (eoy) %0.63.4 19.3%  
Book value per share (Unadj.) Rs84.91,820.6-  
Shares outstanding (eoy) m188.52848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.71.6 227.0%   
Avg P/E ratio x16.226.1 62.1%  
P/CF ratio (eoy) x14.711.4 129.4%  
Price / Book Value ratio x7.31.5 496.1%  
Dividend payout %10.587.5 12.0%   
Avg Mkt Cap Rs m116,3832,262,786 5.1%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m4,2140-   
Avg. sales/employee Rs ThNM30,924.1-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM1,931.8-  
INCOME DATA
Net Sales Rs m31,4871,389,884 2.3%  
Other income Rs m550-   
Total revenues Rs m31,5421,389,884 2.3%   
Gross profit Rs m10,060380,620 2.6%  
Depreciation Rs m722112,346 0.6%   
Interest Rs m3727,300 0.1%   
Profit before tax Rs m9,356240,975 3.9%   
Minority Interest Rs m01,095 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-158,187 0.0%   
Tax Rs m2,160-2,942 -73.4%   
Profit after tax Rs m7,19486,825 8.3%  
Gross profit margin %31.927.4 116.7%  
Effective tax rate %23.1-1.2 -1,891.1%   
Net profit margin %22.86.2 365.8%  
BALANCE SHEET DATA
Current assets Rs m15,066938,722 1.6%   
Current liabilities Rs m7,674818,645 0.9%   
Net working cap to sales %23.58.6 271.7%  
Current ratio x2.01.1 171.2%  
Inventory Days Days6791 73.7%  
Debtors Days Days4196 42.4%  
Net fixed assets Rs m8,237453,967 1.8%   
Share capital Rs m3773,421 11.0%   
"Free" reserves Rs m15,4160-   
Net worth Rs m16,0051,543,897 1.0%   
Long term debt Rs m0710,679 0.0%   
Total assets Rs m24,5943,176,330 0.8%  
Interest coverage x255.29.8 2,597.3%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.30.4 292.6%   
Return on assets %29.43.6 818.3%  
Return on equity %44.95.6 799.3%  
Return on capital %58.74.9 1,189.8%  
Exports to sales %55.70-   
Imports to sales %10.40-   
Net fx Rs m12,4930-   
CASH FLOW
From Operations Rs m9,304221,476 4.2%  
From Investments Rs m-3,105-78,478 4.0%  
From Financial Activity Rs m-1,959-265,675 0.7%  
Net Cashflow Rs m4,240-122,677 -3.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 68.42 Rs / USD

Compare ALEMBIC PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ALEMBIC PHARMA With: GSK PHARMA  FRESENIUS KABI ONCO.  DR. DATSONS LABS  FDC LTD.  LUPIN LTD  



Today's Market

Indian Indices Trade in Red; IPO Buzz, and Top Stocks in Action(Pre-Open)

On Wednesday, share markets in India opened in green and went on to hit a new all-time high. However, selling during the day meant that the benchmark indices ended the day in red.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jul 19, 2018 09:41 AM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS